Cargando…

Withdrawal from Genetic Counselling for Cancer

BACKGROUND: A substantial minority of individuals who initially apply for genetic counselling for breast/ovarian cancer withdraw at an early stage from the counselling process. This study investigated the self-reported reasons for early withdrawal and the factors associated significantly with such w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleiker, Eveline, Wigbout, Gea, van Rens, Anja, Verhoef, Senno, van't Veer, Laura, Aaronson, Neil
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837064/
https://www.ncbi.nlm.nih.gov/pubmed/20223026
http://dx.doi.org/10.1186/1897-4287-3-1-19
_version_ 1782178771864911872
author Bleiker, Eveline
Wigbout, Gea
van Rens, Anja
Verhoef, Senno
van't Veer, Laura
Aaronson, Neil
author_facet Bleiker, Eveline
Wigbout, Gea
van Rens, Anja
Verhoef, Senno
van't Veer, Laura
Aaronson, Neil
author_sort Bleiker, Eveline
collection PubMed
description BACKGROUND: A substantial minority of individuals who initially apply for genetic counselling for breast/ovarian cancer withdraw at an early stage from the counselling process. This study investigated the self-reported reasons for early withdrawal and the factors associated significantly with such withdrawal. METHODS: Self-report questionnaires were mailed to 83 women who had applied for genetic counselling for breast/ovarian cancer but who subsequently withdrew from the counselling process (the "withdrawers"). A comparison group of 105 women who had completed the genetic counselling (the "attendees") received a similar questionnaire. The questionnaire assessed sociodemographic characteristics, reasons for applying for genetic counselling, general distress (MHI-5), cancer-specific distress (IES), and cancer worries. For those women who discontinued the counselling, reasons for withdrawal were also assessed. RESULTS: The primary reasons given for withdrawing from counselling were difficulties in anticipating the consequences of genetic counselling (28%), and worries about being unable to adequately cope with an unfavourable test result (20%). Compared to the attendees, the withdrawers were significantly younger, more frequently asymptomatic, more often the first and only member of the family to apply for counselling, and less worried about cancer. Current levels of cancer-specific distress and general distress were comparable between the two groups. CONCLUSION: Younger women, those without a history of cancer, and those who are first in their family to apply are more likely to withdraw prematurely from genetic counselling for breast/ovarian cancer. These withdrawers have no elevated levels of distress. However, a substantial percentage of individuals discontinue counselling due to concerns about their (in)ability to cope with a possible unfavourable test outcome. This suggests that greater attention should be paid to ways of coping with test results during the very first contact with the clinic.
format Text
id pubmed-2837064
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28370642010-03-12 Withdrawal from Genetic Counselling for Cancer Bleiker, Eveline Wigbout, Gea van Rens, Anja Verhoef, Senno van't Veer, Laura Aaronson, Neil Hered Cancer Clin Pract Research BACKGROUND: A substantial minority of individuals who initially apply for genetic counselling for breast/ovarian cancer withdraw at an early stage from the counselling process. This study investigated the self-reported reasons for early withdrawal and the factors associated significantly with such withdrawal. METHODS: Self-report questionnaires were mailed to 83 women who had applied for genetic counselling for breast/ovarian cancer but who subsequently withdrew from the counselling process (the "withdrawers"). A comparison group of 105 women who had completed the genetic counselling (the "attendees") received a similar questionnaire. The questionnaire assessed sociodemographic characteristics, reasons for applying for genetic counselling, general distress (MHI-5), cancer-specific distress (IES), and cancer worries. For those women who discontinued the counselling, reasons for withdrawal were also assessed. RESULTS: The primary reasons given for withdrawing from counselling were difficulties in anticipating the consequences of genetic counselling (28%), and worries about being unable to adequately cope with an unfavourable test result (20%). Compared to the attendees, the withdrawers were significantly younger, more frequently asymptomatic, more often the first and only member of the family to apply for counselling, and less worried about cancer. Current levels of cancer-specific distress and general distress were comparable between the two groups. CONCLUSION: Younger women, those without a history of cancer, and those who are first in their family to apply are more likely to withdraw prematurely from genetic counselling for breast/ovarian cancer. These withdrawers have no elevated levels of distress. However, a substantial percentage of individuals discontinue counselling due to concerns about their (in)ability to cope with a possible unfavourable test outcome. This suggests that greater attention should be paid to ways of coping with test results during the very first contact with the clinic. BioMed Central 2005-02-15 /pmc/articles/PMC2837064/ /pubmed/20223026 http://dx.doi.org/10.1186/1897-4287-3-1-19 Text en
spellingShingle Research
Bleiker, Eveline
Wigbout, Gea
van Rens, Anja
Verhoef, Senno
van't Veer, Laura
Aaronson, Neil
Withdrawal from Genetic Counselling for Cancer
title Withdrawal from Genetic Counselling for Cancer
title_full Withdrawal from Genetic Counselling for Cancer
title_fullStr Withdrawal from Genetic Counselling for Cancer
title_full_unstemmed Withdrawal from Genetic Counselling for Cancer
title_short Withdrawal from Genetic Counselling for Cancer
title_sort withdrawal from genetic counselling for cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837064/
https://www.ncbi.nlm.nih.gov/pubmed/20223026
http://dx.doi.org/10.1186/1897-4287-3-1-19
work_keys_str_mv AT bleikereveline withdrawalfromgeneticcounsellingforcancer
AT wigboutgea withdrawalfromgeneticcounsellingforcancer
AT vanrensanja withdrawalfromgeneticcounsellingforcancer
AT verhoefsenno withdrawalfromgeneticcounsellingforcancer
AT vantveerlaura withdrawalfromgeneticcounsellingforcancer
AT aaronsonneil withdrawalfromgeneticcounsellingforcancer